Accelerated apoA-I catabolism with decreased apoA-II production patients with end-stage renal disease: Stable isotope studies

被引：0
|
作者：
Ikewaki, K
Schaefer, JR
Okubo, K
Schwarz, S
Kronenberg, F
Schweer, H
Koenig, P
Hosoya, T
Mochizuki, S
Dieplinger, H
机构：
[1] Jikei Univ, Div Cardiol, Sch Med, Tokyo, Japan
[2] Univ Marburg, Dept Internal Med Cardiol, Marburg, Germany
[3] Jikei Univ, Sch Med, Div Nephrol & Hypertens, Tokyo, Japan
[4] Univ Innsbruck, Inst Med Biol & Human Genet, A-6020 Innsbruck, Austria
[5] Univ Marburg, Childrens Hosp, Marburg, Germany
[6] Univ Innsbruck, Dept Clin Nephrol, A-6020 Innsbruck, Austria
来源：
CIRCULATION | 2003年 / 108卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
622
引用
收藏
页码：132 / 132
页数：1
相关论文
共 50 条
  • [21] ANESTHESIA FOR PATIENTS WITH STABLE END-STAGE RENAL-DISEASE
    DYSON, D
    VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE, 1992, 22 (02) : 469 - 471
  • [22] Lipoprotein(a) accelerated the progression of atherosclerosis in patients with end-stage renal disease
    Kun Ling Ma
    Tie Kai Gong
    Ze Bo Hu
    Yang Zhang
    Gui Hua Wang
    Liang Liu
    Pei Pei Chen
    Jian Lu
    Chen Chen Lu
    Bi Cheng Liu
    BMC Nephrology, 19
  • [23] Lipoprotein(a) accelerated the progression of atherosclerosis in patients with end-stage renal disease
    Ma, Kun Ling
    Gong, Tie Kai
    Hu, Ze Bo
    Zhang, Yang
    Wang, Gui Hua
    Liu, Liang
    Chen, Pei Pei
    Lu, Jian
    Lu, Chen Chen
    Liu, Bi Cheng
    BMC NEPHROLOGY, 2018, 19
  • [24] Decreased salivary function in patients with end-stage renal disease requiring hemodialysis
    Kao, CH
    Hsieh, JF
    Tsai, SC
    Ho, YJ
    Chang, HR
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 36 (06) : 1110 - 1114
  • [25] Cognitive impairment in patients with end-stage renal disease: Accelerated brain aging?
    Chiu, Yen-Ling
    Tsai, Hsiu-Hui
    Lai, Yen-Jun
    Tseng, Hsin-Yi
    Wu, Yen-Wen
    Peng, Yu-Sen
    Chiu, Cheng-Ming
    Chuang, Yi-Fang
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2019, 118 (05) : 867 - 875
  • [26] Cardiovascular dysautonomia of patients with end-stage renal disease and type I or type II diabetes
    Hathaway, DK
    Cashion, AK
    Wicks, MN
    Milstead, EJ
    Gaber, AO
    NURSING RESEARCH, 1998, 47 (03) : 171 - 179
  • [27] I-131 Dosimetry for patients with end-stage renal disease
    Worthington, Krystle
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51
  • [28] Is atherosclerosis accelerated in young patients with end-stage renal disease? The contribution of paediatric nephrology
    Querfeld, U
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 (05) : 719 - 722
  • [29] Accelerated Brain Aging in Non-Demented Patients With End-Stage Renal Disease
    Chuang, Yi-Fang
    Tsai, Hsiu-Hui
    Lai, Yen-Jun
    Chiu, Yen-Ling
    BIOLOGICAL PSYCHIATRY, 2019, 85 (10) : S214 - S214
  • [30] Decreased p66Shc promoter methylation in patients with end-stage renal disease
    Geisel, Juergen
    Schorr, Heike
    Heine, Gunar H.
    Bodis, Marion
    Huebner, Ulrich
    Knapp, Jean-Pierre
    Herrmann, Wolfgang
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2007, 45 (12) : 1764 - 1770
12345